MSMorten Smerup

Morten Smerup

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Morten Smerup has a total of 202 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical characteristics, treatment, and outcomes in CIED-related versus left-sided infective endocarditis: a nationwide study from the NIDUS registry

    by Amna Alhakak, Peter Laursen Graversen, Katra Hadji-Turdeghal, Jacob Eifer Møller, Niels Eske Bruun, Anne-Christine Ruwald, Peter Godsk Jørgensen, Andreas Dalsgaard Jensen, Jeppe K Petersen, Mohammed Bakir Ahmad Lafta, et al.

    Structured Background and Aims: Cardiac implantable electronic device (CIED)-related infective endocarditis (IE) presents distinct diagnostic and therapeutic challenges due to its unique characteristics and limited evidence supporting guidelines compared with left-sided valvular IE. We aimed to examine clinical characteristics, treatment, and mortality in patients with CIED-related IE versus left-sided valvular IE. Methods: We included patients with first-time IE using nationwide data from the NatIonal Danish endocarditis StUdieS (NIDUS) registry (2016-2021) and categorised them into isolated CIED-related IE without concomitant valvular IE and left-sided valvular IE. Results: A total of 340 patients with isolated CIED-related IE and 2,510 patients with left-sided IE were included. Patients with CIED-related IE vs. left-sided IE were older (76.1 vs. 73.2 years), and a higher proportion were males (78.5% vs. 65.9%), had diabetes (32.9% vs. 21.9%), heart failure (46.2% vs. 11.7%), Staphylococcus aureus (37.1% vs. 30.7%), coagulase-negative staphylococci (11.2% vs. 6.4%), and culture-negative IE (12.1% vs. 7.8%). However, fever at admission was lower in CIED-related IE (55.4% vs. 61.5%). CIED removal was performed in 78.2% of patients with CIED-related IE. The six-month cumulative incidence of mortality was 20.4% (95% CI:16.2-24.9%) in CIED-related IE and 26.8% (95% CI:25.1-28.6%) in left-sided IE (P=0.009). In a multivariable Cox regression model, CIED-related IE was associated with lower six-month mortality compared with left-sided IE (adjusted HR:0.52 [95% CI:0.40–0.68], P<0.001). Conclusion: In this nationwide study, patients with CIED-related IE were distinctly different from those with left-sided IE. Staphylococci were more prevalent, and despite higher age and differences in comorbidities, mortality was lower.


  • Open Access

    Clinical characteristics, treatment strategies, and outcomes of patients with aortic valve infective endocarditis with and without aortic root abscess: insights from the NIDUS registry

    by Thea Stybe, Amna Alhakak, Peter Laursen Graversen, Katra Hadji-Turdeghal, Niels Eske Bruun, Jacob Eifer Møller, Jeppe K Petersen, Andreas Dalsgaard Jensen, Jonas A Povlsen, Claus Ernst Moser, et al.

    Background and Aims: Aortic root abscess is a severe and diagnostically challenging complication of infective endocarditis (IE). This study aimed to examine differences between IE patients with and without aortic root abscesses in patient characteristics, treatment strategies, and clinical outcomes. Methods: We conducted nationwide, unselected, registry-based cohort study using National Danish Endocarditis Studies registry. All patients with aortic valve endocarditis in Denmark from 2016 to 2021 were included. Clinical and microbiological characteristics, treatment, and mortality were compared according to status of aortic root abscess. Mortality was adjusted for clinically relevant covariates. Results: The study population included 1902 patients with aortic endocarditis, of whom 316 (17%) had an aortic root abscess. Patients with an abscess versus those without were significantly younger (median 71.5 vs 75.1 years, P-value ≤.001), more often male (76.3% vs. 69.7%, P-value = .02), prosthetic valve (50.0% vs. 30.4%, P-value ≤.001), AV-block (10% vs 1.7%, P-value ≤.001), coagulase-negative staphylococci and streptococci in their blood cultures, and were surgically treated (59.5% vs 16.1%). In multivariable Cox regression, patients with abscesses had significantly higher 1-year mortality rate compared with those without (HR 1.41, 95% CI: 1.13–1.76). When stratifying for surgery, non-operated patients with an abscess had the highest 1-year mortality 55.4%, alongside a high pre-operative risk (median age 79, 38% not self-reliant, more comorbidities including 12% active cancer). Conclusions: Aortic root abscess was present in 17% of patients with aortic valve endocarditis and was associated with distinct clinical and microbiological characteristics, a higher frequency of complications, greater prevalence of surgery albeit a higher mortality rate compared with those without an abscess.


  • Mitral valve replacement or repair and long-term risk of infective endocarditis: a Danish nationwide study

    by Amna Alhakak, Jawad Haider Butt, Eva Havers-Borgersen, Lauge Østergaard, Peter Laursen Graversen, Jarl Emanuel Strange, Katia Al-Chaer, Morten Holdgaard Smerup, Henning Bundgaard, Lars Køber, et al.

    Background and Aims: Infective endocarditis (IE) after mitral valve (MV) interventions is a serious complication. However, information on the long-term risk of first-time IE after MV replacement or repair is lacking. The 10-year incidence of first-time IE was examined in patients undergoing MV replacement or repair, compared with those at moderate risk of IE. Methods: Using Danish nationwide registries (2000–2020), the study population included patients undergoing isolated MV replacement or repair and patients at moderate risk of IE. The moderate-risk group included cardiac implantable electronic devices, congenital heart valve anomalies, hypertrophic cardiomyopathy, rheumatic heart diseases, and non-rheumatic degenerative valve diseases. The Aalen–Johansen estimator and cause-specific Cox regression models were used to determine the 10-year comparative incidences of IE. Results: The study population included 1220 patients undergoing MV replacement, 3239 undergoing MV repair, and 209 517 at moderate risk of IE. The 10-year cumulative incidences of IE were 6.1% [95% confidence interval (CI) 4.8%–7.7%] for MV replacement, 1.6% (95% CI 1.1%–2.1%) for MV repair, and 1.7% (95% CI 1.6%–1.7%) for the moderate-risk group. Compared with the moderate-risk group, after multivariable adjustment, MV replacement was associated with a higher 10-year IE rate (hazard ratio 3.52, 95% CI 2.73–4.52), whereas MV repair was not associated with IE (hazard ratio 0.76, 95% CI 0.56–1.04). Conclusions: In this nationwide study, MV replacement was associated with a 3.5-fold increased 10-year IE rate, whereas MV repair was not significantly associated with IE, compared with patients at moderate risk of IE. These findings highlight the need for further investigation into preventive measures, including targeted antibiotic prophylaxis.


  • Open Access

    Impact of acute kidney injury and dysnatremia on length of stay in infants after cardiac surgery

    by Jonas Rønne Kronborg, Rasmus Bo Lindhardt, Niels Vejlstrup, Line Marie Holst, Klaus Juul, Morten Holdgaard Smerup, Jakob Gjedsted, Hanne Berg Ravn

    Background: Acute kidney injury (AKI) and dysnatremia following pediatric cardiac surgery are common conditions associated with worse outcomes. While the multifactorial etiology of AKI is well-known, the role of concomitant dysnatremia is limited. This study aims to describe the occurrence of AKI, its association with the length of stay in the intensive care unit (ICU-LOS), and the impact of dysnatremia in the context of AKI. Methods: Retrospective study comprising 228 congenital heart procedures in 213 infants at Rigshospitalet, Copenhagen, Denmark, from 2017 to 2019. AKI development was evaluated separately in neonates and infants > 1 month and its impact on ICU-LOS. Risk factors for AKI were analyzed across age groups using the univariate and multivariate logistic regression analysis. Results: AKI occurred in 61% of neonates and 62% of infants. Severity was comparable across age groups, except for KDIGO-stage 3, where seven out of eight children treated with peritoneal dialysis were neonates. Urine output was well-preserved despite AKI development, but children with AKI required more than double the furosemide dose. In multivariate analysis, prolonged cardiopulmonary bypass (CPB) duration, higher furosemide doses, and hypernatremia were independently associated with AKI. AKI was only associated with prolonged ICU-LOS in infants, while hyponatremia was associated with prolonged ICU-LOS in all individuals with AKI. Conclusions: AKI occurs frequently in neonates and infants after congenital heart surgery but is only associated with prolonged ICU-LOS in infants. The co-occurrence of AKI and hyponatremia leads to longer ICU-LOS in both neonates and infants. Independent predictors of AKI were prolonged CPB duration, hypernatremia, and reduced furosemide sensitivity. Graphical


  • Bacteraemia and infective endocarditis following left-sided heart valve surgery

    by Christine Holgersson, Lauge Østergaard, Eva Havers-Borgersen, Anna Stahl, Katra Hadji-Turdeghal, Amna Alhakak, Marianne Voldstedlund, Morten Smerup, Christian Torp-Pedersen, Lars Køber, et al.

    In patients undergoing heart valve surgery, subsequent bacteremia and infective endocarditis are feared events. Data on the incidence and bacterial microbiological etiology following left-sided heart valve surgery are sparse. Between 2010–2021, all patients undergoing left-sided valve surgery were identified using Danish nationwide registries. Incidence and type bacteremia within one-year post-surgery was analyzed. Secondary outcome of interest was infective endocarditis. Cumulative incidence curves were stratified for bacterial species and for subgroups of interest: type of valve surgery, age, and sex. A total of 14 935 patients were included, of which 69% were male and the median age was 70.4 years (25th-75th percentile 62.4–76.2 years). The one-year cumulative incidence of bacteremia was 6.1% (95% CI 5.7–6.5%), and the most frequent bacteremia was coagulase-negative staphylococci (27%). More than half of the bacteremia with coagulase-negative staphylococci occurred within 30 days of follow-up. Patients developing bacteremia had a significantly higher Charlson comorbidity score at baseline, more often underwent CABG concomitant to valve surgery, and more often had surgery on both valves. The one-year cumulative incidence of infective endocarditis was 1.5% (95% CI 1.3–1.7), of which 23% were caused by Enterococci, and 22% were blood culture negative. The median time from surgery to infective endocarditis was 109 days. Bacteremia and infective endocarditis following left-sided heart valve surgery occurred in 6.1% and 1.5% of patients, respectively. The most frequent bacteremia was coagulase-negative staphylococci, and more than half of these occurred within 30 days of surgery. Optimization of prophylactic strategies are warranted.


  • Open Access

    Infective endocarditis with or without congenital heart disease: clinical features and outcomes

    by Eva Havers-Borgersen, Lauge Østergaard, Christine Kjærsgaard Holgersson, Anna Stahl, Michael Rahbek Schmidt, Morten Smerup, Lars Køber, Emil L Fosbøl

    Patients with congenital heart disease (CHD) form a high-risk subgroup for infective endocarditis (IE), necessitating tailored prevention and treatment strategies. However, comprehensive nationwide data comparing IE characteristics and outcomes in patients with and without CHD, including children, are sparse. This study aims to address this gap in knowledge. Using Danish nationwide registries, all patients with IE from 1977 to 2021 were identified and stratified on whether they had a diagnosis of CHD, regardless of its complexity. Characteristics prior to and during admission as well as associated outcomes (i.e. in-hospital mortality, 1-year mortality, and 10-year mortality, and IE recurrence) were compared between groups. In total, 14 040 patients with IE were identified, including 895 (6.4%) with CHD. Patients with vs. without CHD were younger at the time of IE diagnosis (median age 38.8 vs. 70.7 years), less comorbid, and more frequently underwent cardiac surgery during admission (35.7% vs. 23.0%, P < .001). Notably, 76% of patients with IE < 18 years of age had CHD. The IE-related bacteraemia differed between groups: Streptococci (29.9%) were the most common in patients with CHD, and Staphylococcus aureus (29.9%) in patients without CHD. Patients with CHD had a significantly lower cumulative incidence of in-hospital mortality (5.7% vs. 17.0%, P < .001) and 1-year mortality (9.9% vs. 31.8%, P < .001) compared with those without CHD. The 10-year cumulative incidence of IE recurrence was similar between groups (13.0% and 13.9%, P = .61). Patients with CHD who develop IE exhibit distinct characteristics and improved long-term outcomes compared with patients without CHD. Notably, the majority of children and adolescents with IE have underlying CHD. The figure summarizes the study design and the main findings of the manuscript. CHD, congenital heart disease; IE, infective endocarditis.


  • Open Access

    Implantable cardioverter defibrillator therapy in paediatric patients for primary vs. secondary prevention

    by Jani Thuraiaiyah, Berit Thornvig Philbert, Annette Schophuus Jensen, Lucas Yixi Xing, Troels Hoejsgaard Joergensen, Chee Woon Lim, Frederikke Noerregaard Jakobsen, Pernille Steen Bække, Michael Rahbek Schmidt, Lars Idorn, et al.

    The decisions about placing an ICD in a child are more difficult than in an adult due to longer expected lifespan and the complication risk. Young patients gain the most years from ICDs, despite higher risk of device-related complications. The secondary prevention ICD indication is clear, and device is implanted regardless of potential complications. For primary prevention, risk of sudden cardiac death and complications need to be evaluated. We aimed to compare outcomes for primary and secondary prevention ICDs. Retrospective nationwide cohort study including paediatric patients identified from the Danish ICD registry with ICD implanted at an age ≤ 15 from 1982–21. Demographics, complications (composite of device-related infections or lead-failure requiring re-operation, mortality because of arrhythmia, or unknown cause), and mortality were retrieved from medical charts. Endpoint was appropriate therapy (shock or anti-tachycardia pacing for ventricular tachycardia or fibrillation). Of 72 receiving an ICD, the majority had channelopathies (n = 34) or structural heart diseases (n = 28). ICDs were implanted in 23 patients for primary prevention and 49 for secondary prevention, at median ages of 13.8 and 11.6 years (P-value 0.01), respectively. Median follow-up was 9.0 (interquartile ranges: 4.7–13.5) years. The 10-year cumulative incidence of first appropriate therapy was 70%, with complication and inappropriate therapy rates at 41% and 15%, respectively. No difference was observed between prevention groups for all outcomes. Six patients died during follow-up. In children, two-thirds are secondary prevention ICDs. Children have higher appropriate therapy and complication rates than adults, while the inappropriate therapy rate was low.


  • Prognostic impact of anaemia in patients undergoing aortic valve replacement: a nationwide study

    by Daniel Alexander Brems, Jeppe Kofoed Petersen, Xenia Begun, Morten Smerup, Jawad Haider Butt, Lars Køber, Emil Fosbøl

    Background: Patients undergoing aortic valve replacement (AVR) have high readmission rates. Several risk factors have been proposed as potential modifiable targets, including anaemia. We examined the association between anaemia at discharge and subsequent outcomes in these patients. Methods and results: Using Danish nationwide registries, we identified all patients who underwent AVR between 2015 and 2021, were alive at discharge (index date), and had an available haemoglobin (Hb) measurement taken between the procedure and discharge. Patients were categorized as having (i) moderate/severe anaemia (Hb <6.2 mmol/L) or (ii) no/mild anaemia (Hb ≥6.2 mmol). The 1-year rates of all-cause mortality, all-cause hospital admission, heart failure (HF) admission, and atrial fibrillation (AF) admission were compared using multivariable Cox regression models. A total of 8614 patients were identified; 2847 (33.1%) had moderate/severe anaemia (60.2% male, median age 74) and 5767 (66.9%) had no/mild anaemia (68.0% male, median age 76). For these two groups, respectively, the cumulative 1-year incidences of the outcomes were: (i) all-cause mortality: 5.1% vs. 4.3%; (ii) all-cause admission: 53.8% vs. 47.5%; (iii) AF admission: 14.0% vs. 11.6%; and (iv) HF admission: 6.8% vs. 6.2%. In adjusted analysis, moderate/severe anaemia, compared with no/mild anaemia, was associated with higher rates of all-cause mortality (hazard ratio (HR) 1.27 [95% confidence interval CI 1.02–1.58]), all-cause admission (HR 1.22 [95% CI 1.14–1.30]), and AF admission (HR 1.23 [95% CI 1.08–1.40]), but not HF admission (HR 1.09 [95% CI 0.91–1.31]). Conclusions: In patients undergoing AVR, moderate/severe anaemia at discharge, compared with no/mild anaemia, was associated with increased all-cause mortality, all-cause hospital admission, and AF admission, but not HF admission, at 1-year post-discharge.


  • Open Access

    Surgery in patients with infective endocarditis and prognostic importance of patient frailty

    by Peter Laursen Graversen, Lauge Østergaard, Morten Holdgaard Smerup, Jarl Emanuel Strange, Katra Hadji-Turdeghal, Marianne Voldstedlund, Lars Køber, Emil Fosbøl

    Purpose: Surgery is required in 20–50% of patients with infective endocarditis (IE). Frailty increases surgical risk; however, the prognostic implications of frailty in patients undergoing IE-related surgery remain poorly understood. We aimed to assess the association between frailty and all-cause mortality or rehospitalization after discharge (≥ 14 days). Methods: We identified all IE patients who underwent surgery during admission (2010–2020) in Denmark. The Hospital Frailty Risk Score was used to categorize patients into two frailty risk groups, patients with low frailty scores (< 5 points) and frail patients (≥ 5 points). We analyzed time hospitalized after discharge and all-cause mortality from the date of surgery with a one-year follow-up. Statistical analyses utilized the Kaplan–Meier estimator, Aalen–Johansen estimator, and the Cox regression model. Results: We identified 1282 patients who underwent surgery during admission, of whom 967 (75.4%) had low frailty scores, and 315 (24.6%) were frail. Frail patients were characterized by advanced age, a lower proportion of males, and a higher burden of comorbidities. Frail patients were more hospitalized (> 14 days) in the first post-discharge year (19.1% vs.12.3%) compared to patients with low frailty scores. Additionally, frail patients had higher rates of all-cause mortality including in-hospital deaths (27% vs. 15%) and rehospitalizations (43.5% vs 26.1%) compared to patients with low frailty scores. This was also evident in the adjusted analysis (hazard ratio 1.36 [CI 95% 1.09–1.71]). Conclusion: Frailty was associated with an ≈40% increased rate of rehospitalization (≥ 14 days) or death. Further studies are needed to assess the effectiveness of surgery with a focus on frailty to improve prognostic outcomes in these patients.


  • Open Access

    Postoperative free water administration is associated with dysnatremia after congenital heart disease surgery in infants

    by Jonas Rønne Kronborg, Rasmus Bo Lindhardt, Niels Vejlstrup, Line Marie Holst, Klaus Juul, Morten Holdgaard Smerup, Jakob Gjedsted, Hanne Berg Ravn

    Dysnatremia after congenital heart disease (CHD) surgery is common. European guidelines on intraoperative fluid therapy in children recommend isotonic solutions to avoid hyponatremia, but prolonged cardiopulmonary bypass and administration of high sodium‐containing solutions (i.e., blood products and sodium bicarbonate) are associated with postoperative hypernatremia. The aim of the study was to describe fluid composition prior to and during the development of postoperative dysnatremia. A retrospective observational, single‐center study including infants undergoing CHD surgery. Demographics and clinical characteristics were registered. Highest and lowest plasma sodium values were recorded and associations with perioperative fluid administration, blood products, crystalloids, and colloids were explored in relation to three perioperative periods. Postoperative dysnatremia occurred in nearly 50% of infants within 48 h after surgery. Hypernatremia was mainly associated with administration of blood products (median [IQR]: 50.5 [28.4–95.5] vs. 34.5 [18.5–61.1] mL/kg; p = 0.001), and lower free water load (1.6 [1.1–2.2] mL/kg/h; p = 0.01). Hyponatremia was associated with a higher free water load (2.3 [1.7–3.3] vs. 1.8 [1.4–2.5] mL/kg/h; p = 0.001) and positive fluid balance. On postoperative day 1, hyponatremia was associated with higher volumes of free water (2.0 [1.5–2.8] vs. 1.3 [1.1–1.8] mL/kg/h; p < 0.001) and human albumin, despite a larger diuresis and more negative daily fluid balance. Postoperative hyponatremia occurred in 30% of infants despite restrictive volumes of hypotonic maintenance fluid, whereas hypernatremia was mainly associated with blood product transfusion. Individualized fluid therapy, with continuous reassessment to reduce the occurrence of postoperative dysnatremia is mandatory in pediatric cardiac surgery. Prospective studies to evaluate fluid therapy in pediatric cardiac surgery patients are warranted.